MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10147-026-03118-8

Медицинская библиотека · International journal of clinical oncology · 2026

Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.

Kawanaka Yusuke, Inagaki Chiaki, Okura Masaki, Mitani Seiichiro, Shiraishi Naoki, Sakai Kazuko, Nishio Kazuto, Kimura Yutaka, Chiba Yasutaka, Wakasa Tomoko, Kawakami Hisato, Hayashi Hidetoshi

СтатьяПеревод в очереди

Аннотация

BACKGROUND

CLDN18.2-targeted therapies show promise in HER2-negative, CLDN18.2-positive advanced gastric cancer (GC); however, cutoffs defining CLDN18.2 positivity vary across studies. Tumors with high expression (moderate to strong membranous expression in ≥ 75% of tumor cells) generally exhibit intratumoral homogeneity and a uniform staining pattern, but intratumoral heterogeneity and staining pattern of CLDN18.2 at lower expression thresholds remains unclear. This study investigated intratumoral heterogeneity of CLDN18.2 by comparing inter-block concordance of expression levels and staining patterns in GC.

METHODS

Eighty-six resected GC specimens were retrospectively analyzed using CLDN18.2 immunohistochemistry on two tissue blocks per tumor. CLDN18.2 expression was categorized as high (≥ 75%), intermediate (< 75% and ≥ 40%), or negative (< 40%), and staining patterns as uniform or variable. Inter-block concordance of expression levels and staining patterns and their influence on concordance and outcomes were assessed.

RESULTS

Overall inter-block concordance of expression levels was high (77%, κ = 0.89). Discordance was substantially higher in intermediate expression tumors (63.5%) than in high (15.5%) or negative (19%) expression tumors. Uniform staining was observed exclusively in high expression tumors, whereas all intermediate expression tumors displayed variable staining (100%). Among high expression tumors, inter-block concordance was substantially higher with uniform staining (98.0%) than with variable staining (71.5%). CLDN18.2 expression and staining pattern heterogeneity were not associated with worse survival.

CONCLUSION

Significant intratumoral heterogeneity of CLDN18.2 expression was observed in GC, particularly in intermediate expression tumors; however, this heterogeneity does not affect survival. These results highlight the importance of standardized assessment methods when applying lower thresholds for CLDN18.2-targeted therapies.

Для цитирования: Kawanaka Yusuke, Inagaki Chiaki, Okura Masaki, Mitani Seiichiro, Shiraishi Naoki, Sakai Kazuko, Nishio Kazuto, Kimura Yutaka, Chiba Yasutaka, Wakasa Tomoko, Kawakami Hisato, Hayashi Hidetoshi. Intratumoral heterogeneity of intermediate CLDN18.2 expression in gastric cancer.. International journal of clinical oncology. 2026. DOI: 10.1007/s10147-026-03118-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.